WFMZ-TV

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...
Taiwan News

BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on ...

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE)-- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by ...
ascopubs.org

Global Approach to Oncology Leadership: The GOLD Program

Leadership is essential for addressing global challenges in cancer care. Equipped with leadership skills, health care providers can respond effectively to complex oncology issues in diverse settings, ...
Morningstar

First-in-Human Use of CereVasc® eShunt® System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes

BOSTON, March 4, 2026 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel minimally invasive treatments for neurological diseases, today announced the publication ...
Santa Clara University

Writing Program

The JST Academic Writing Program offers academic writing coaching and writing workshops to all degree-seeking JST students. We provide one-to-one coaching services on a variety of topics, such as ...
Naples Daily News

CareTrack’s Remote Patient Monitoring Program Demonstrates Early Success Across Tanner Health Practices

CARROLLTON, GA, UNITED STATES, January 30, 2026 /EINPresswire.com/ — CareTrack, a leading provider of remote healthcare solutions, is excited to announce positive ...